IP Verse

Dr. Reddy's Laboratories Limited opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Dr. Reddy's Laboratories Limited

Patent Number:
EP2478907
Title:
Methods And Compositions For Treating Cancer
Applicant:
COUGAR BIOTECHNOLOGY, INC.
Opposition Date:
Jan 14, 2022
Patent Number:
EP2766040
Title:
Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor Pertuzumab
Applicant:
F. HOFFMANN-LA ROCHE AG
Opposition Date:
Feb 17, 2020
Patent Number:
EP2825558
Title:
Combination Therapy For The Treatment Of Ovarian Cancer
Applicant:
F. HOFFMANN-LA ROCHE AG
Opposition Date:
Feb 17, 2020
Patent Number:
EP3111954
Title:
Methods Of Treating Ankylosing Spondylitis Or Psoriatic Arthritis Using Anti-Il-17 Antibodies
Applicant:
NOVARTIS AG
Opposition Date:
Jan 2, 2020
Patent Number:
EP3300721
Title:
Propylene Glycol-Containing Peptide Formulations Which Are Optimal For Production And For Use In Injection Devices
Applicant:
NOVO NORDISK A/S
Opposition Date:
Dec 5, 2019
Patent Number:
EP2962690
Title:
(+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione: Methods Of Using And Compositions Thereof
Applicant:
AMGEN (EUROPE) GMBH
Opposition Date:
Oct 16, 2019
Patent Number:
EP2238172
Title:
Composition Comprising Antibody That Binds To Domain Ii Of Her2 And Acidic Variants Thereof
Applicant:
GENENTECH, INC.
Opposition Date:
Nov 21, 2018
Patent Number:
EP2704798
Title:
Formulation For Anti- Alpha4Beta7 Antibody
Applicant:
MILLENNIUM PHARMACEUTICALS, INC.
Opposition Date:
Apr 12, 2018

Latest patents of Dr. Reddy's Laboratories Limited opposed by its competitors

Patent:
EP3414256
Grant Date:
Jan 19, 2022
Title:
Amine Salt Of Obeticholic Acid
Oppositions:
1
Patent:
EP2809773
Grant Date:
Sep 2, 2020
Title:
Process Of Modulating Man5 And/Or Afucosylation Content Of Glycoprotein Composition
Oppositions:
5

Competitors of Dr. Reddy's Laboratories Limited

F. HOFFMANN-LA ROCHE AG

F.HOFFMANN-LA ROCHE AG

AMGEN (EUROPE) GMBH

Want to track Dr. Reddy's Laboratories Limited?

Feel free to send us a message here and we will get back to you